The Predictive Value of Inflammation-Related Peripheral Blood Measurements in Cancer Staging and Prognosis

In this review, we discuss the interaction between cancer and markers of inflammation (such as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of routinely monitoring these markers in peripheral blood measurement assays. Next, we discuss the prognostic value and limitations of using inflammatory markers such as neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and C-reactive protein measurements. Furthermore, the review discusses the benefits of combining multiple types of measurements and longitudinal tracking to improve staging and prognosis prediction of patients with cancer, and the ability of novel in silico frameworks to leverage this high-dimensional data.

[1]  T. Wagner,et al.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer. , 2017, Convergent science physical oncology.

[2]  Liang Zhou,et al.  The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer , 2017, Oncotarget.

[3]  V. Pergialiotis,et al.  The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer , 2017, Inflammation Research.

[4]  V. Pergialiotis,et al.  The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer , 2017, Inflammation Research.

[5]  B. Graubard,et al.  Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial , 2017, Journal of the National Cancer Institute.

[6]  J. Borgia,et al.  Relationships between longitudinal neutrophil to lymphocyte ratios, body weight changes, and overall survival in patients with non-small cell lung cancer , 2017, BMC Cancer.

[7]  R. Sears,et al.  Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC. , 2017, American journal of physiology. Cell physiology.

[8]  Sean C. Bendall,et al.  Systemic Immunity Is Required for Effective Cancer Immunotherapy , 2017, Cell.

[9]  M. Caricato,et al.  Neutrophil to Lymphocyte Ratio (NLR) and Derived Neutrophil to Lymphocyte Ratio (d-NLR) Predict Non-Responders and Postoperative Complications in Patients Undergoing Radical Surgery After Neo-Adjuvant Radio-Chemotherapy for Rectal Adenocarcinoma , 2016, Cancer investigation.

[10]  Zhengshui Xu,et al.  The Prognostic Role of the Platelet-Lymphocytes Ratio in Gastric Cancer: A Meta-Analysis , 2016, PloS one.

[11]  C. Hannan,et al.  A Systematic Review of the Prognostic Role of Hematologic Scoring Systems in Patients With Renal Cell Carcinoma Undergoing Nephrectomy With Curative Intent. , 2016, Clinical genitourinary cancer.

[12]  A. Gerger,et al.  Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection , 2016, PloS one.

[13]  Yanqing Wang,et al.  Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy , 2016, BMC Cancer.

[14]  Y. Hiramatsu,et al.  Neutrophil to lymphocyte ratio in the pre-treatment phase of final-line chemotherapy predicts the outcome of patients with recurrent ovarian cancer , 2016, Oncology letters.

[15]  M. Polat,et al.  Neutrophil to lymphocyte and platelet to lymphocyte ratios increase in ovarian tumors in the presence of frank stromal invasion , 2016, Clinical and Translational Oncology.

[16]  Francesco Pappalardo,et al.  Computational modeling in melanoma for novel drug discovery , 2016, Expert opinion on drug discovery.

[17]  David S Schneider,et al.  Tracking Resilience to Infections by Mapping Disease Space , 2016, PLoS biology.

[18]  A. Alberg,et al.  Neutrophil‐to‐lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma , 2016, Head & neck.

[19]  Jing Wang,et al.  STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment. , 2016, Cancer research.

[20]  M. Bakacak,et al.  Utility of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios to distinguish malignant from benign ovarian masses. , 2016, Journal of the Turkish German Gynecological Association.

[21]  D. Walsh,et al.  C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review , 2015, PloS one.

[22]  Walter F. Stewart,et al.  Doctor AI: Predicting Clinical Events via Recurrent Neural Networks , 2015, MLHC.

[23]  F. Su,et al.  The Peripheral Blood Neutrophil-To-Lymphocyte Ratio Is Superior to the Lymphocyte-To-Monocyte Ratio for Predicting the Long-Term Survival of Triple-Negative Breast Cancer Patients , 2015, PloS one.

[24]  Charles Elkan,et al.  Learning to Diagnose with LSTM Recurrent Neural Networks , 2015, ICLR.

[25]  L. Holmberg,et al.  Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patients. , 2015, Carcinogenesis.

[26]  D. Tiezzi,et al.  IL17 Promotes Mammary Tumor Progression by Changing the Behavior of Tumor Cells and Eliciting Tumorigenic Neutrophils Recruitment. , 2015, Cancer research.

[27]  Giulia Russo,et al.  Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations , 2015, Bioinform..

[28]  T. Ozawa,et al.  The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer , 2015, International Journal of Colorectal Disease.

[29]  Q. Nunes,et al.  Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[30]  Jin Won Lee,et al.  The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer? , 2015, Annals of Surgical Oncology.

[31]  H. Chung,et al.  Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study , 2015, Cancer research and treatment : official journal of Korean Cancer Association.

[32]  Melahat Yildirim,et al.  Differentiation between benign and malignant ovarian masses in the preoperative period using neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios. , 2015, Molecular and clinical oncology.

[33]  Yu-qin Pan,et al.  Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model , 2015, Journal of Translational Medicine.

[34]  J. Waldron,et al.  Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status , 2015, Cancer.

[35]  A. Belldegrun,et al.  The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma. , 2015, Urologic oncology.

[36]  A. Dirican,et al.  Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? , 2015, International Journal of Clinical Oncology.

[37]  Ping Liu,et al.  Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer , 2015, Cancer Chemotherapy and Pharmacology.

[38]  E. Tajara,et al.  Inflammation and Cancer: Role of Annexin A1 and FPR2/ALX in Proliferation and Metastasis in Human Laryngeal Squamous Cell Carcinoma , 2014, PloS one.

[39]  S. Boorjian,et al.  Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy. , 2014, Urologic oncology.

[40]  Yu-qin Pan,et al.  The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients , 2014, Medical Oncology.

[41]  Noémie Elhadad,et al.  Identifying and mitigating biases in EHR laboratory tests , 2014, J. Biomed. Informatics.

[42]  Stuart B. Goodman,et al.  Clinical recovery from surgery correlates with single-cell immune signatures , 2014, Science Translational Medicine.

[43]  P. Kornprat,et al.  The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. , 2014, American journal of surgery.

[44]  I. Yücel,et al.  Mean platelet volume could be a useful biomarker for monitoring epithelial ovarian cancer , 2014, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[45]  A. Gerger,et al.  The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas , 2014, International journal of cancer.

[46]  M. Khattak,et al.  Prognostic value of systemic inflammation‐based markers in advanced pancreatic cancer , 2014, Internal medicine journal.

[47]  Tongshan Wang,et al.  Prognostic Value of PLR in Various Cancers: A Meta-Analysis , 2014, PloS one.

[48]  H. Ling,et al.  The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer , 2014, British Journal of Cancer.

[49]  U. Langsenlehner,et al.  The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients , 2014, British Journal of Cancer.

[50]  Y. Zeng,et al.  A Large Cohort Study Reveals the Association of Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio with Favorable Prognosis in Nasopharyngeal Carcinoma , 2013, PloS one.

[51]  H. Samonigg,et al.  The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer , 2013, British Journal of Cancer.

[52]  A. Belldegrun,et al.  Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma. , 2013, The Journal of urology.

[53]  P. Kornprat,et al.  Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients , 2013, British Journal of Cancer.

[54]  C. Garlanda,et al.  Tumor associated macrophages and neutrophils in cancer. , 2013, Immunobiology.

[55]  S. Clarke,et al.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. , 2013, Critical reviews in oncology/hematology.

[56]  M. Saito,et al.  The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and Fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma. , 2013, Urologic oncology.

[57]  Ş. Balta,et al.  Neutrophil to Lymphocyte Ratio May Predict Mortality in Breast Cancer Patients , 2013, Journal of breast cancer.

[58]  D. McMillan.  The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. , 2013, Cancer treatment reviews.

[59]  H. Samonigg,et al.  A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients , 2013, British Journal of Cancer.

[60]  T. Burnouf,et al.  The platelet-cancer loop. , 2013, European journal of internal medicine.

[61]  Francesco Pappalardo,et al.  Mathematical modeling of biological systems , 2013, Briefings Bioinform..

[62]  D. McMillan,et al.  Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer , 2013, British Journal of Cancer.

[63]  P. Kornprat,et al.  Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer , 2013, British Journal of Cancer.

[64]  S. Lang,et al.  Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. , 2013, Seminars in cancer biology.

[65]  D. Wagner,et al.  Neutrophil histone modification by peptidylarginine deiminase 4 is critical for deep vein thrombosis in mice , 2013, Proceedings of the National Academy of Sciences.

[66]  K. Du,et al.  Platelet count predicts prognosis in operable non-small cell lung cancer , 2013, Experimental and therapeutic medicine.

[67]  Seungok Lee,et al.  Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma , 2013, BMC Cancer.

[68]  K. Pummer,et al.  Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients , 2013, British Journal of Cancer.

[69]  F. Wang,et al.  Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer , 2013, Medical Oncology.

[70]  V. Bhatt,et al.  Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients , 2013, Medical Oncology.

[71]  N. Erez,et al.  From sentinel cells to inflammatory culprits: cancer‐associated fibroblasts in tumour‐related inflammation , 2013, The Journal of pathology.

[72]  S. Tangjitgamol,et al.  Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer , 2012, Journal of gynecologic oncology.

[73]  M. Kuczyk,et al.  Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients , 2012, BMC Cancer.

[74]  D. McMillan,et al.  Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. , 2012, American journal of surgery.

[75]  H. Tajiri,et al.  Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma , 2012, British Journal of Cancer.

[76]  S. Clarke,et al.  A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer , 2012, British Journal of Cancer.

[77]  Fenghua Wang,et al.  Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer , 2012, Tumor Biology.

[78]  M. Sospedra,et al.  T Lymphocyte Priming by Neutrophil Extracellular Traps Links Innate and Adaptive Immune Responses , 2012, The Journal of Immunology.

[79]  J. Edwards,et al.  Prospective Study of the Role of Inflammation in Renal Cancer , 2012, Urologia Internationalis.

[80]  S. Motoyama,et al.  Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes , 2012, Surgery Today.

[81]  W. Chiu,et al.  Paraneoplastic thrombocytosis in ovarian cancer. , 2012, The New England journal of medicine.

[82]  D. Wagner,et al.  Neutrophil extracellular traps promote deep vein thrombosis in mice , 2012, Journal of thrombosis and haemostasis : JTH.

[83]  D. McMillan,et al.  Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems , 2011, British Journal of Cancer.

[84]  Y. K. Park,et al.  Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer , 2011, Journal of surgical oncology.

[85]  V. Bhatt,et al.  Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Short- and Long-Term Mortality in Breast Cancer Patients , 2011, Annals of Surgical Oncology.

[86]  T. Kinoshitá,et al.  Predictive Value of Baseline Neutrophil/Lymphocyte Ratio for T4 Disease in Wall-Penetrating Gastric Cancer , 2011, World Journal of Surgery.

[87]  Q. Sun,et al.  Prognostic Role of C-Reactive Protein in Breast Cancer: A Systematic Review and Meta-Analysis , 2011, The International journal of biological markers.

[88]  H. Nishimatsu,et al.  Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? , 2011, The Journal of urology.

[89]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[90]  C. Holmes,et al.  The platelet contribution to cancer progression , 2011, Journal of thrombosis and haemostasis : JTH.

[91]  N. Jamieson,et al.  A Prospective Comparison of the Prognostic Value of Tumor- and Patient-Related Factors in Patients Undergoing Potentially Curative Surgery for Pancreatic Ductal Adenocarcinoma , 2011, Annals of Surgical Oncology.

[92]  G. Motohashi,et al.  Evaluations of interferon‐γ/interleukin‐4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients , 2010, Journal of surgical oncology.

[93]  M. Horwitz,et al.  Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.

[94]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[95]  Kaoru Kobayashi,et al.  Elevated C-Reactive Protein and Hypoalbuminemia Measured before Resection of Colorectal Liver Metastases Predict Postoperative Survival , 2010, Digestive Surgery.

[96]  D. McMillan,et al.  Is Hypoalbuminemia an Independent Prognostic Factor in Patients with Gastric Cancer? , 2010, World Journal of Surgery.

[97]  K. Ogan,et al.  Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. , 2010, The Journal of urology.

[98]  Cynthia S. Johnson,et al.  Pancreatic Acinar Cell Carcinoma: A Multi-institutional Study , 2009, Journal of Gastrointestinal Surgery.

[99]  B. Davidson,et al.  Serum C-reactive protein concentration and the prognosis of ductal adenocarcinoma of the head of pancreas. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[100]  S. Bojesen,et al.  Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[101]  J. Neoptolemos,et al.  Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. , 2009, American journal of surgery.

[102]  K. Kihara,et al.  Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. , 2008, The Journal of urology.

[103]  H. Kölbl,et al.  The humoral immune system has a key prognostic impact in node-negative breast cancer. , 2008, Cancer research.

[104]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[105]  D. McMillan,et al.  Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse‐free and cancer‐specific survival in patients undergoing potentially curative resection for renal cancer , 2008, BJU international.

[106]  Mark Bates,et al.  Three-Dimensional Super-Resolution Imaging by Stochastic Optical Reconstruction Microscopy , 2008, Science.

[107]  Chi-Jung Huang,et al.  Is C-Reactive Protein a Prognostic Factor of Colorectal Cancer? , 2008, Diseases of the colon and rectum.

[108]  D. McMillan,et al.  Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer , 2007, British Journal of Cancer.

[109]  Y. Komai,et al.  Increased preoperative serum C‐reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma , 2007, BJU international.

[110]  Anneclaire J De Roos,et al.  Differences in Survival by Histologic Type of Pancreatic Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[111]  R. Yu,et al.  Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-α and IL-6 , 2005 .

[112]  J. D. De Larco,et al.  The Potential Role of Neutrophils in Promoting the Metastatic Phenotype of Tumors Releasing Interleukin-8 , 2004, Clinical Cancer Research.

[113]  A Senthilselvan,et al.  Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis , 2004, Thorax.

[114]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[115]  S. Taysı,et al.  Levels of some acute-phase proteins in the serum of patients with cancer during radiotherapy. , 2003, Biological & pharmaceutical bulletin.

[116]  H. Matsubara,et al.  Elevation of preoperative serum C‐reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma , 2003, Journal of surgical oncology.

[117]  S. Weitzman,et al.  Chronic inflammation and cancer. , 2002, Oncology.

[118]  H. Adami,et al.  Infections as a major preventable cause of human cancer , 2000, Journal of internal medicine.

[119]  O. McCarty,et al.  Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. , 2000, Blood.

[120]  G Bellone,et al.  Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients. , 1999, The American journal of pathology.

[121]  B. Echtenacher,et al.  Lysis of tumor cells by natural killer cells in mice is impeded by platelets. , 1999, Cancer research.

[122]  L R Dixon,et al.  The Complete Blood Count: Physiologic Basis and Clinical Usage , 1997, The Journal of perinatal & neonatal nursing.

[123]  G. Assmann,et al.  Association of Variables of Coagulation, Fibrinolysis and Acute-phase with Atherosclerosis in Coronary and Peripheral Arteries and those Arteries Supplying the Brain , 1995, Thrombosis and Haemostasis.

[124]  M. Blaser,et al.  Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. , 1995, Cancer research.

[125]  F. Beuvon,et al.  Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. , 1994, Journal of the National Cancer Institute.

[126]  M. Colombo,et al.  Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma , 1993, The Journal of experimental medicine.

[127]  S. Weitzman,et al.  Inflammation and cancer: role of phagocyte-generated oxidants in , 2011 .

[128]  C. Stewart,et al.  Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[129]  A. Gautier,et al.  C-reactive protein , 2005 .

[130]  B. Yucel,et al.  The utility of tumor markers and neutrophil lymphocyte ratio in patients with an intraoperative diagnosis of mucinous borderline ovarian tumor. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[131]  A. Tokmak,et al.  Value of the platelet to lymphocyte ratio in the diagnosis of ovarian neoplasms in adolescents. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[132]  Fan Long,et al.  Principled Sampling for Anomaly Detection , 2015, NDSS.

[133]  K. Ogan,et al.  External validation of the modified Glasgow prognostic score for renal cancer , 2014, Indian journal of urology : IJU : journal of the Urological Society of India.

[134]  T. Hagemann,et al.  Cancer-Related Inflammation , 2012, Journal of Clinical Immunology.

[135]  會澤 雅樹.  Predictive value of baseline neutrophil/lymphocyte ratio for T4 disease in wall-penetrating gastric cancer , 2012 .

[136]  小池 勇樹.  Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer , 2009 .

[137]  Sung Hoon Kim,et al.  Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment , 2008, Cancer Immunology, Immunotherapy.

[138]  R. Yu,et al.  Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. , 2005, Diabetes research and clinical practice.

[139]  G. Hospers,et al.  Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor , 2004, Angiogenesis.

[140]  K. Fearon,et al.  Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer. , 1999, Clinical science.

[141]  A. Flahault,et al.  Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. , 1998, The American journal of pathology.

[142]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.